Advances in the Treatment of Yaws
AbstractYaws is one of the three endemic treponematoses and is recognised by the World Health Organization as a neglected tropical disease. Yaws is currently reported in 15 countries in the Pacific, South-East Asia, West and Central Africa, predominantly affects children, and results in destructive lesions of the skin and soft tissues. For most of the twentieth century penicillin-based treatment was the standard of care and resistance to penicillin has still not been described. Recently, oral azithromycin has been shown to be an effective treatment for yaws, facilitating renewed yaws eradication efforts. Resistance to azithromycin is an emerging threat and close surveillance will be required as yaws eradication efforts are scaled up globally. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Marks, M. Advances in the Treatment of Yaws. Trop. Med. Infect. Dis. 2018, 3, 92.
Marks M. Advances in the Treatment of Yaws. Tropical Medicine and Infectious Disease. 2018; 3(3):92.Chicago/Turabian Style
Marks, Michael. 2018. "Advances in the Treatment of Yaws." Trop. Med. Infect. Dis. 3, no. 3: 92.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.